KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

AbCellera Biologics (ABCL) Tax Provisions (2021 - 2023)

AbCellera Biologics (ABCL) has disclosed Tax Provisions for 3 consecutive years, with -$1.5 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Tax Provisions rose 4.48% year-over-year to -$1.5 million, compared with a TTM value of -$27.6 million through Dec 2023, down 134.29%, and an annual FY2024 reading of -$37.5 million, down 35.85% over the prior year.
  • Tax Provisions was -$1.5 million for Q4 2023 at AbCellera Biologics, up from -$10.7 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $62.2 million in Q1 2022 and bottomed at -$10.7 million in Q3 2023.
  • Average Tax Provisions over 3 years is $9.9 million, with a median of -$776000.0 recorded in 2022.
  • The sharpest move saw Tax Provisions surged 655.76% in 2022, then plummeted 7301.98% in 2023.
  • Year by year, Tax Provisions stood at $24.8 million in 2021, then plummeted by 106.13% to -$1.5 million in 2022, then rose by 4.48% to -$1.5 million in 2023.
  • Business Quant data shows Tax Provisions for ABCL at -$1.5 million in Q4 2023, -$10.7 million in Q3 2023, and -$7.5 million in Q2 2023.